Riskpilot← Back to searchSign inGet full accessAdmirabilis AB
ABActiveOrg 5590596085Folkskolegatan 20General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2024
SEK 309K
-63% vs 2023
EBITDA margin
-74.3%
-3568% vs 2023
Equity ratio
71.9%
Financial strength
Net profit 2024
SEK 52K
-80% vs 2023
| Revenue | SEK 309K | -63% |
| EBITDA | SEK -229K | -3568% |
| Net profit | SEK 52K | -80% |
| Total assets | SEK 2,8M | -27% |
| Equity | SEK 2M | -8% |
| Employees | 1 | — |
Legal name
Admirabilis AB
Org number
5590596085
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 april 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva sjukvård och sjukvårdsutbildning. Bolaget skall även bedriva skönhetskonsultation, medicinskbehandling, utbildning och kursverksamhet inom skönhet. Bolaget ska utföra estetiska samt plastikkirurgiska behandlingar. Försäljning av hud och skönhetsvårdsprodukter, kosmetika och behandlingar. Bolaget skall köpa och sälja antikviteter och konst, handel och sälja tjänster inom bildkonst och design, samt äga och förvalta fastigheter även som idka därmed förenlig verksamhet.
Address
Folkskolegatan 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 336 | 945 | 1 512 | 839 | 309 |
| Staff expenses | — | — | −425 | −402 | −109 |
| EBITDA | −83 | 106 | 574 | 7 | −229 |
| Depreciation & amort. | −25 | −25 | −23 | −4 | −4 |
| EBIT | −108 | 81 | 551 | 2 | −233 |
| Net financials | 421 | 87 | 0 | 81 | −7 |
| Profit before tax | 351 | 168 | 611 | 344 | 80 |
| Tax | −78 | −37 | −131 | −81 | −28 |
| Net profit | 273 | 131 | 480 | 263 | 52 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 620 | 3 481 | 3 964 | 3 924 | 2 845 |
| Equity | 1 940 | 2 071 | 2 451 | 2 214 | 2 046 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 549 | 221 | 384 | 842 | 251 |
| Total debt | 549 | 221 | 384 | 842 | 251 |
EBITDA margin
-74.3%
This company
15.8%
Market median
-570% vs market
20202024
Equity ratio
71.9%
This company
38.2%
Market median
+88% vs market
20202024
Return on equity
2.5%
This company
18.4%
Market median
-86% vs market
20202024
Net profit margin
16.7%
This company
8.1%
Market median
+106% vs market
20202024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20202024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Admirabilis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Radu Vasilcanu | Deputy Board Member | 0 companies |
| Marin Florica | Board of Directors | 0 companies |